Latest KFF Health News Stories
KHN’s ‘What the Health?’: Our 200th Episode!
The federal approval of a controversial drug to treat Alzheimer’s disease has reignited the debate over drug prices and the way the Food and Drug Administration makes decisions. Meanwhile, President Joe Biden seeks to gain goodwill overseas as he announces the U.S. will provide 500 million doses of covid vaccine to international health efforts. Sarah Karlin-Smith of the Pink Sheet, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Chiquita Brooks-LaSure, the new administrator of the Centers for Medicare & Medicaid Services. And to mark the podcast’s 200th episode, the panelists discuss what has surprised them most and least over the past four years.
Kidney Experts Say It’s Time to Remove Race From Medical Algorithms. Doing So Is Complicated.
When estimating how well a patient’s kidneys are working, doctors frequently turn to an equation that depends on a question: Is the patient Black? Kidney experts are now debating how to remove the race adjustment and whether the question is a function of sound science. It’s considered just the first step in dismantling institutional racism in kidney care.
Montana Med School Clash Revives For-Profit Vs. Nonprofit Flap
Two medical schools vie to open in Montana, highlighting the rapid spread of for-profit schools and their previously tarnished business model.
KHN’s ‘What the Health?’: The Drug Price Dilemma
Republicans, Democrats and the public at large agree that prices for prescription drugs are too high. But no one seems to know how to fix it. Vanderbilt University drug price researcher Stacie Dusetzina explains the basics of why drugs cost so much and why it’s hard to do something about it. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss the prospects for policy changes.
Biden Administration Signals It’s in No Rush to Allow Canadian Drug Imports
Federal officials asked a court to dismiss a suit by drugmakers over the policy enacted by the Trump administration that would allow states to bring in cheaper prescription medications from Canada. The filing said the lawsuit was moot because it’s unclear when or if the FDA would approve any state’s importation plan.
The number of Americans 65 and older is expected to nearly double in the next 40 years. Finding a way to provide and pay for the long-term health services they need won’t be easy.
Suficiente para arruinar el descanso: le cobran $10,322 por un estudio del sueño
Por un estudio del sueño para resolver su apnea, recibió una factura que es seis veces superior a la que paga Medicare.
Enough to Wreck Their Rest: $10,322 for a Sleep Study
The University of Miami Health System charges a truck driver six times what Medicare would pay for an overnight test.
As Pandemic Eases, Many Seniors Have Lost Strength, May Need Rehabilitative Services
A little-discussed, long-term toll of the pandemic is that large numbers of older adults have become physically and cognitively debilitated and less able to care for themselves after sheltering in place.
‘Kicking You When You’re Down’: Many Cancer Patients Pay Dearly for Parking
Patients often fork over payments comparable to valet rates to park while receiving care. A recent study found that some of the country’s most prestigious cancer centers charge nearly $1,700 over the course of treatment for some types of the disease.
KHN’s ‘What the Health?’: Drug Price Effort Hits a Snag
Democratic leaders in Congress have vowed to pass legislation to address high prescription drug prices this year, but some moderates in their own party appear to be balking. Meanwhile, younger teens are now eligible for a covid-19 vaccine and the Biden administration reinstated anti-discrimination policy for LGBTQ people in health care. Joanne Kenen of Politico, Sarah Karlin-Smith of the Pink Sheet and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more.
Mental Health Services Wane as Insurers Appear to Skirt Parity Rules During Pandemic
A report from the Government Accountability Office paints a picture of an already strained behavioral health system struggling after the pandemic struck to meet the treatment needs of millions of Americans with conditions like alcohol use disorder and post-traumatic stress disorder.
Big Investors Push Nursing Homes to Upgrade Care and Working Conditions
Responsible for 34% of the nation’s covid death toll, nursing homes and long-term care facilities get slammed by their investors and are told to change.
UVA Health Will Wipe Out Tens of Thousands of Lawsuits Against Patients
The Virginia hospital giant had already stopped suing patients with less than $107,000 in household income.
Expertos en salud pública temen que los fondos desaparezcan cuando termine la pandemia
El Congreso ha enviado miles de millones a los departamentos de salud para luchar contra covid. Pero históricamente, esta financiación se acaba cuando termina la emergencia sanitaria.
Public Health Experts Worry About Boom-Bust Cycle of Support
Congress has poured tens of billions of dollars into public health since last year. While health officials who have juggled bare-bones budgets for years are grateful for the money, they worry it will soon dry up, just as it has after previous crises such as 9/11, SARS and Ebola. Meanwhile, they continue to cope with an exodus from the field amid political pressure and exhaustion that meant 1 in 6 Americans lost their local health department leader.
Biden Seeks $400 Billion to Buttress Long-Term Care. A Look at What’s at Stake.
Long-term care options are expensive and often out of reach for seniors and people with disabilities. The president has proposed a massive infusion of federal funding for home and community-based health services that advocates say will go a long way toward helping individuals and families.
They Tested Negative for Covid. Still, They Have Long Covid Symptoms.
Despite a negative covid test, people could have been infected with the coronavirus anyway. And some of them might face lingering health issues.
Medicamentos ya conocidos, y baratos, podrían ser clave para tratar covid
Hay medicamentos aprobados hace años que podrían investigarse en profundidad para tratar covid. Pero no hay interés porque no generarían grandes ganancias.
Scientists Seek Covid Treatment Answers in Cheap, Older Drugs
Philanthropies are funding studies of cheap, existing medications like the antidepressant fluvoxamine as covid treatments. But early hype about hydroxychloroquine and other repurposed drugs leaves researchers leery of hasty conclusions.
